In murine models, IGFBP-3 inhibits insulin-stimulated glucose uptake [17], while over-expression of IGFBP-3 in male transgenic mice results in fasting hyperglycaemia, impaired glucose tolerance, and insulin resistance [18]. The gene discussed is INS; the disease is Hyperglycemia.